Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $308M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 374,000 | $28.23M | 9.2% | $42.82 | +47.1% | COM | 03770N101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,750,000 | $21.14M | 6.9% | $3.96 | +242.6% | COM | 03237H101 |
| ZURA | ZURA BIO LTD | 3,815,930 | $20M | 6.5% | $5.64 | -29.9% | CLASS A ORD SHS | G9TY5A101 |
| IRON | DISC MEDICINE INC | 250,000 | $19.85M | 6.4% | $84.50 | 0.0% | COM | 254604101 |
| RAPT | RAPT THERAPEUTICS INC | 581,187 | $19.68M | 6.4% | $31.06 | 0.0% | COM NEW | 75382E208 |
| IMVT | IMMUNOVANT INC | 750,000 | $19.07M | 6.2% | $19.88 | +12.2% | COM | 45258J102 |
| SLNO | SOLENO THERAPEUTICS INC | 400,000 | $18.52M | 6.0% | $65.69 | -16.5% | COM | 834203309 |
| VOR | VOR BIOPHARMA INC | 1,370,107 | $17.92M | 5.8% | $18.62 | 0.0% | COM NEW | 929033207 |
| DNTH | DIANTHUS THERAPEUTICS INC | 350,000 | $14.42M | 4.7% | $28.73 | +34.9% | COM | 252828108 |
| JBIO | JADE BIOSCIENCES INC | 806,273 | $12.44M | 4.0% | $24.47 | -52.1% | COM NEW | 008064206 |
| KALV | KALVISTA PHARMACEUTICALS INC | 685,632 | $11.07M | 3.6% | $13.24 | 0.0% | COM | 483497103 |
| CTNM | CONTINEUM THERAPEUTICS INC | 800,000 | $9.144M | 3.0% | $11.41 | 0.0% | CL A | 21217B100 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $9.06M | 2.9% | $5.44 | +13.3% | COM | 29842P105 |
| FULC | FULCRUM THERAPEUTICS INC | 800,000 | $9.048M | 2.9% | $10.18 | 0.0% | COM | 359616109 |
| NKTR | NEKTAR THERAPEUTICS | 210,732 | $8.91M | 2.9% | $33.10 | +69.1% | COM NEW | 640268306 |
| UPB | UPSTREAM BIO INC | 300,000 | $8.145M | 2.6% | $22.33 | +11.5% | COM | 91678A107 |
| NGNE | NEUROGENE INC | 350,000 | $7.21M | 2.3% | $14.71 | +69.2% | COM | 64135M105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 300,000 | $6.9M | 2.2% | $32.88 | 0.0% | COM | 90400D108 |
| CNTX | CONTEXT THERAPEUTICS INC | 4,683,711 | $6.885M | 2.2% | $1.72 | -32.2% | COM | 21077P108 |
| CGEM | CULLINAN THERAPEUTICS INC | 634,032 | $6.562M | 2.1% | $9.02 | 0.0% | COM | 230031106 |
| EVMN | EVOMMUNE INC | 325,000 | $5.564M | 1.8% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| ORKA | ORUKA THERAPEUTICS INC | 183,330 | $5.557M | 1.8% | $14.82 | +88.0% | COM | 687604108 |
| SLN | SILENCE THERAPEUTICS PLC | 808,032 | $4.913M | 1.6% | $6.08 | — | ADS | 82686Q101 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 796,558 | $4.596M | 1.5% | $6.18 | -13.7% | COM NEW | 90466Y202 |
| CLYM | CLIMB BIO INC | 979,534 | $3.918M | 1.3% | $2.40 | 0.0% | COM | 28658R106 |
| SANA | SANA BIOTECHNOLOGY INC | 700,000 | $2.849M | 0.9% | $3.62 | +23.9% | COM | 799566104 |
| PHVS | PHARVARIS N V | 82,800 | $2.298M | 0.7% | $22.18 | +8.6% | COM | N69605108 |
| AVTX | AVALO THERAPEUTICS INC | 124,666 | $2.264M | 0.7% | $16.88 | 0.0% | COM NEW | 05338F306 |
| RZLT | REZOLUTE INC | 951,809 | $2.246M | 0.7% | $4.03 | +94.6% | COM NEW | 76200L309 |